Physician profile
Michael B Wiese
NPI 1538137005
$4,586.58
in general payments reported to CMS, 2019-2025
12 companies · $65.19 in 2025
The $65.19 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $3,194 · 2021: $132 · 2022: $252 · 2023: $233 · 2024: $262 · 2025: $65.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,503.50 | 2020 | |
| Prodigy Surgical Distribution, INC. | $497.12 | 2020 | |
| Smith+Nephew, INC. | $465.94 | 2019-2024 | Evos, Trigen Intertan, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $362.04 | 2019-2021 | |
| Depuy Synthes Sales INC. | $196.34 | 2019-2024 | Orthovisc, Monovisc |
| Fidia Pharma USA INC. | $179.33 | 2019-2025 | Hymovis |
| Sanofi-Aventis U.S. LLC | $117.24 | 2019-2024 | |
| Pacira Pharmaceuticals Incorporated | $81.97 | 2022-2024 | Exparel, Zilretta, Iovera |
| Nevro Corp. | $67.60 | 2024 | Senza |
| Bioventus LLC | $48.14 | 2020-2023 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $44.98 | 2019-2021 | |
| Ethicon US, LLC | $22.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wiese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.